ARS Pharmaceuticals, Inc. SPRY Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from ARS Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s price / sales?
- ARS Pharmaceuticals, Inc. (SPRY) reported price / sales of 8.1× in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s price / sales changed year-over-year?
- ARS Pharmaceuticals, Inc.'s price / sales decreased by 36.6% year-over-year, from 12.7× to 8.1×.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s price / sales?
- Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s price / sales has grown at a -41.1% compound annual growth rate (CAGR), from 113.4× to 13.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.